Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Data on Tardive Dyskinesia Improvement and Stability of Psychiatric Symptoms at American Psychiatric Association Annual Meeting 2022 - GuruFocus.com
Submitted by Anonymous (not verified) on Tue, 07/12/2022 - 13:58
